03461nam 2200649 a 450 991083037570332120230421044618.01-282-13792-197866121379210-470-51467-10-470-51468-X(CKB)1000000000377313(EBL)470529(SSID)ssj0000367260(PQKBManifestationID)11252344(PQKBTitleCode)TC0000367260(PQKBWorkID)10418510(PQKB)11263840(MiAaPQ)EBC470529(OCoLC)181177712(EXLCZ)99100000000037731319940802d1994 uy 0engur|n|---|||||txtccrVaccines against virally induced cancers[electronic resource]Chichester ;New York J. Wiley19941 online resource (293 p.)Ciba Foundation symposium ;187"Ciba Foundation"--Cover.Symposium held at the Ciba Foundation, London, 15-17 March 1994, based on a proposal by Ian Frazer.0-471-95026-2 Includes bibliographical references and indexes.VACC I N ES AGAl NST VIRALLY INDUCED CANCERS; Contents; Participants; Introdu ction; Potential antigenic targets on Epstein - Bar r vir us-associated tumours and the host response; The host response to lesions induced by human papillomavirus; General discussion I; Human T cell lymphotropic virus: necessity for and feasibility of a vaccine; Vaccination against cutaneous and mucosal papillomavirus in cattle; Strategies for studying mouse and human immune responses to human papillomavirus type 16Prospects for T cell immunotherapy of tumours by vaccination with immunodominant and su bdominant peptidesHepatitis B virus infection, the immune response and hepatocellular carcinoma; The role of superantigens in the immunobiology of retroviruses; General discussion I I; Assembly and transport of class I MHC-peptide complexes; Induction and regulation of CD4+ T cell subsets; Propagation of mouse and human T cells with defined antigen specificity and function; Immunity to the HER-2heu oncogenic proteinGenetic modification of T cell clones to improve the safety and efficacy of adoptive T cell therapyBone marrow-derived cells present MHC class I-restricted tumour antigens in priming of antiturnour immune responses; Evasion of host immune responses by tumours and viruses; Final dscussion; Index of contributors; Subject indexAn interdisciplinary and multinational group of specialists present contributions describing the current status of vaccines against virally induced tumors and discuss the means by which they can be improved.Ciba Foundation symposium ;187.Viral carcinogenesisCongressesViral vaccinesCongressesCancerImmunotherapyCongressesViral carcinogenesisViral vaccinesCancerImmunotherapy616.99616.992061Frazer I. H(Ian H.)1679514Ciba Foundation.MiAaPQMiAaPQMiAaPQBOOK9910830375703321Vaccines against virally induced cancers4047808UNINA